ID   PP2BB_RAT               Reviewed;         525 AA.
AC   P20651; Q6LDJ7;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-OCT-2024, entry version 177.
DE   RecName: Full=Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform;
DE            EC=3.1.3.16 {ECO:0000250|UniProtKB:P16298};
DE   AltName: Full=CAM-PRP catalytic subunit;
DE   AltName: Full=Calmodulin-dependent calcineurin A subunit beta isoform;
DE            Short=CNA beta {ECO:0000250|UniProtKB:P16298};
GN   Name=Ppp3cb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2558657; DOI=10.1016/0006-291x(89)92752-6;
RA   Kuno T., Takeda T., Hirai M., Ito A., Mukai H., Tanaka C.;
RT   "Evidence for a second isoform of the catalytic subunit of calmodulin-
RT   dependent protein phosphatase (calcineurin A).";
RL   Biochem. Biophys. Res. Commun. 165:1352-1358(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 245-315.
RX   PubMed=2174876; DOI=10.1016/s0021-9258(18)45767-5;
RA   Wadzinski B.E., Heasley L.E., Johnson G.L.;
RT   "Multiplicity of protein serine-threonine phosphatases in PC12
RT   pheochromocytoma and FTO-2B hepatoma cells.";
RL   J. Biol. Chem. 265:21504-21508(1990).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=23699505; DOI=10.1523/jneurosci.4288-12.2013;
RA   Kim S.H., Ryan T.A.;
RT   "Balance of calcineurin Aalpha and CDK5 activities sets release probability
RT   at nerve terminals.";
RL   J. Neurosci. 33:8937-8950(2013).
RN   [4]
RP   INTERACTION WITH SLC12A1 AND SORL1, AND TISSUE SPECIFICITY.
RX   PubMed=25967121; DOI=10.1681/asn.2014070728;
RA   Borschewski A., Himmerkus N., Boldt C., Blankenstein K.I., McCormick J.A.,
RA   Lazelle R., Willnow T.E., Jankowski V., Plain A., Bleich M., Ellison D.H.,
RA   Bachmann S., Mutig K.;
RT   "Calcineurin and sorting-related receptor with A-type repeats interact to
RT   regulate the renal Na(+)-K(+)-2Cl(-) cotransporter.";
RL   J. Am. Soc. Nephrol. 27:107-119(2016).
CC   -!- FUNCTION: Calcium-dependent, calmodulin-stimulated protein phosphatase
CC       which plays an essential role in the transduction of intracellular
CC       Ca(2+)-mediated signals. Dephosphorylates TFEB in response to lysosomal
CC       Ca(2+) release, resulting in TFEB nuclear translocation and stimulation
CC       of lysosomal biogenesis. Dephosphorylates and activates transcription
CC       factor NFATC1. Dephosphorylates and inactivates transcription factor
CC       ELK1. Dephosphorylates DARPP32 (By similarity). Negatively regulates
CC       MAP3K14/NIK signaling via inhibition of nuclear translocation of the
CC       transcription factors RELA and RELB (By similarity). May play a role in
CC       skeletal muscle fiber type specification (By similarity).
CC       {ECO:0000250|UniProtKB:P16298, ECO:0000250|UniProtKB:P48453}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000250|UniProtKB:P16298};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC         Evidence={ECO:0000250|UniProtKB:P16298};
CC   -!- COFACTOR:
CC       Name=Fe(3+); Xref=ChEBI:CHEBI:29034;
CC         Evidence={ECO:0000250|UniProtKB:P16298};
CC       Note=Binds 1 Fe(3+) ion per subunit. {ECO:0000250|UniProtKB:P16298};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P16298};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P16298};
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)-bound calmodulin following an
CC       increase in intracellular Ca(2+). At low Ca(2+) concentrations, the
CC       catalytic subunit (also known as calcineurin A) is inactive and is
CC       bound to the regulatory subunit (also known as calcineurin B) in which
CC       only two high-affinity binding sites are occupied by Ca(2+). In
CC       response to elevated calcium levels, the occupancy of the low-affinity
CC       sites on calcineurin B by Ca(2+) causes a conformational change of the
CC       C-terminal regulatory domain of calcineurin A, resulting in the
CC       exposure of the calmodulin-binding domain and in the partial activation
CC       of calcineurin A. The subsequent binding of Ca(2+)-bound calmodulin
CC       leads to the displacement of the autoinhibitory domain from the active
CC       site and possibly of the autoinhibitory segment from the substrate
CC       binding site which fully activates calcineurin A.
CC       {ECO:0000250|UniProtKB:P16298}.
CC   -!- SUBUNIT: Forms a complex composed of a calmodulin-dependent catalytic
CC       subunit (also known as calcineurin A) and a regulatory Ca(2+)-binding
CC       subunit (also known as calcineurin B). There are three catalytic
CC       subunits, each encoded by a separate gene (PPP3CA, PPP3CB, and PPP3CC)
CC       and two regulatory subunits which are also encoded by separate genes
CC       (PPP3R1 and PPP3R2). In response to an increase in Ca(2+) intracellular
CC       levels, forms a complex composed of PPP3CB/calcineurin A, calcineurin B
CC       and calmodulin. Interacts (via calcineurin B binding domain) with
CC       regulatory subunit PPP3R1/calcineurin B. Interacts (via calmodulin-
CC       binding domain) with calmodulin; the interaction depends on calmodulin
CC       binding to Ca(2+). Interacts with SLC12A1 (PubMed:25967121). Interacts
CC       with SORL1 (PubMed:25967121). Interacts with UNC119 (By similarity).
CC       Interacts with MAP3K14/NIK (via C-terminus and kinase domain) (By
CC       similarity). Interacts with TRAF3 (By similarity). Interacts with
CC       SPATA33 (via PQIIIT motif) (By similarity). Interacts with IRGM;
CC       promoting its association with TFEB and TFEB dephosphorylation (By
CC       similarity). {ECO:0000250|UniProtKB:P16298,
CC       ECO:0000250|UniProtKB:P48453, ECO:0000269|PubMed:25967121}.
CC   -!- INTERACTION:
CC       P20651; Q9WVC7: Akap6; NbExp=2; IntAct=EBI-7400670, EBI-7559840;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P16298}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney (at protein level)
CC       (PubMed:25967121). Expressed in hippocampal presynaptic termini (at
CC       protein level) (PubMed:23699505). {ECO:0000269|PubMed:23699505,
CC       ECO:0000269|PubMed:25967121}.
CC   -!- DOMAIN: The poly-Pro domain may confer substrate specificity.
CC       {ECO:0000250|UniProtKB:P16298}.
CC   -!- DOMAIN: The autoinhibitory domain prevents access to the catalytic
CC       site. {ECO:0000250|UniProtKB:P16298}.
CC   -!- DOMAIN: The autoinhibitory segment prevents access to the substrate
CC       binding site. {ECO:0000250|UniProtKB:P16298}.
CC   -!- DOMAIN: Possible isomerization of Pro-318 within the SAPNY motif
CC       triggers a conformation switch which affects the organization and thus
CC       accessibility of the active site and the substrate binding region
CC       (PxIxIF motif). The trans- to cis-transition may favor calcineurin A
CC       activation and substrate binding. The reverse cis- to trans-transition
CC       may be enhanced by peptidyl-prolyl isomerases such as PPIA.
CC       {ECO:0000250|UniProtKB:Q08209}.
CC   -!- MISCELLANEOUS: Unlike for protein substrates, PPP3CB activity towards
CC       synthetic phosphatase substrate p-nitrophenyl phosphate (pNPP) is
CC       increased in presence of the immunosuppressant complex FKBP12-FK506.
CC       {ECO:0000250|UniProtKB:P16298}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-2B subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M31809; AAA40848.1; -; mRNA.
DR   EMBL; D90036; BAA14084.1; -; mRNA.
DR   EMBL; M58441; AAA41915.1; -; mRNA.
DR   PIR; A33794; A33794.
DR   RefSeq; NP_058738.1; NM_017042.2.
DR   AlphaFoldDB; P20651; -.
DR   SMR; P20651; -.
DR   BioGRID; 246807; 3.
DR   CORUM; P20651; -.
DR   DIP; DIP-66N; -.
DR   IntAct; P20651; 5.
DR   MINT; P20651; -.
DR   STRING; 10116.ENSRNOP00000074339; -.
DR   iPTMnet; P20651; -.
DR   PhosphoSitePlus; P20651; -.
DR   jPOST; P20651; -.
DR   PaxDb; 10116-ENSRNOP00000010476; -.
DR   GeneID; 24675; -.
DR   KEGG; rno:24675; -.
DR   UCSC; RGD:3383; rat.
DR   AGR; RGD:3383; -.
DR   CTD; 5532; -.
DR   RGD; 3383; Ppp3cb.
DR   eggNOG; KOG0375; Eukaryota.
DR   InParanoid; P20651; -.
DR   OrthoDB; 1488111at2759; -.
DR   PhylomeDB; P20651; -.
DR   Reactome; R-RNO-2025928; Calcineurin activates NFAT.
DR   Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   PRO; PR:P20651; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005955; C:calcineurin complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0030315; C:T-tubule; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0004723; F:calcium-dependent protein serine/threonine phosphatase activity; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0033192; F:calmodulin-dependent protein phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; ISS:UniProtKB.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046983; F:protein dimerization activity; ISO:RGD.
DR   GO; GO:0030346; F:protein phosphatase 2B binding; ISS:UniProtKB.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0097720; P:calcineurin-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0033173; P:calcineurin-NFAT signaling cascade; ISO:RGD.
DR   GO; GO:0017156; P:calcium-ion regulated exocytosis; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; ISO:RGD.
DR   GO; GO:0001946; P:lymphangiogenesis; ISO:RGD.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IEP:RGD.
DR   GO; GO:0023057; P:negative regulation of signaling; ISS:UniProtKB.
DR   GO; GO:0001915; P:negative regulation of T cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:1905673; P:positive regulation of lysosome organization; ISO:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; IDA:UniProtKB.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; ISO:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; ISO:RGD.
DR   GO; GO:0006950; P:response to stress; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; ISO:RGD.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; ISO:RGD.
DR   CDD; cd07416; MPP_PP2B; 1.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR041751; MPP_PP2B.
DR   InterPro; IPR043360; PP2B.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   PANTHER; PTHR45673; SERINE/THREONINE-PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT 1-RELATED; 1.
DR   PANTHER; PTHR45673:SF7; SERINE_THREONINE-PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT BETA ISOFORM; 1.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; Metallo-dependent phosphatases; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Calmodulin-binding; Cytoplasm; Hydrolase; Iron; Metal-binding;
KW   Phosphoprotein; Protein phosphatase; Reference proteome; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   CHAIN           2..525
FT                   /note="Serine/threonine-protein phosphatase 2B catalytic
FT                   subunit beta isoform"
FT                   /id="PRO_0000058827"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          65..356
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   REGION          357..379
FT                   /note="Calcineurin B binding"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   REGION          402..416
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   REGION          417..424
FT                   /note="Autoinhibitory segment"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   REGION          475..497
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   MOTIF           316..320
FT                   /note="SAPNY motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q08209"
FT   ACT_SITE        160
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q08209"
FT   BINDING         99
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         101
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         127
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         159
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         208
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   BINDING         290
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P16298"
FT   MOD_RES         479
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48453"
SQ   SEQUENCE   525 AA;  59113 MW;  5E66AF3100BE3987 CRC64;
     MAAPEPARAA PPPPPPPPPP LGADRVVKAV PFPPTHRLTS EEVFDMDGIP RVDVLKNHLV
     KEGRVDEEIA LRIINEGAAI LRREKTMIEV EAPITVCGDI HGQFFDLMKL FEVGGSPANT
     RYLFLGDYVD RGYFSIECVL YLWVLKILYP STLFLLRGNH ECRHLTEYFT FKQECKIKYS
     ERVYEACMEA FDSLPLAALL NQQFLCVHGG LSPEIHTLDD IRRLDRFKEP PAFGPMCDLL
     WSDPSEDFGN EKSQEHFSHN TVRGCSYFYN YPAVCEFLQN NNLLSIIRAH EAQDAGYRMY
     RKSQTTGFPS LITIFSAPNY LDVYNNKAAV LKYENNVMNI RQFNCSPHPY WLPNFMDVFT
     WSLPFVGEKV TEMLVNVLSI CSDDELMTEG EDQFDVGSAA ARKEIIRNKI RAIGKMARVF
     SVLREESESV LTLKGLTPTG MLPSGVLAGG RQTLQSATVE AIEAEKAIRG SSPPHRICSF
     EEAKGLDRIN ERMPPRKDAV QQDGFNSLNT AHTTENHGTG NHSAQ
//
